Organization (Government)
Spanish National Research Council
ClinicalTrials.gov lists Spanish National Research Council as lead sponsor of 11 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 1 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.8 trial starts a year over the five years to September, under the 5 a year the method needs. 1 trial is registered to start in 2027 or later.
This page covers Spanish National Research Council: 11 lead-sponsored trials and 0 legal-entity registrations.
Related companies are recorded in the same corporate group by GLEIF, ROR or a curator but are not grouped here; they are listed below with their own counts and are not included in the figures above.
Disease areas (29)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Inflammation | 10 |
| Obesity | 8 |
| Insulin Resistance | 5 |
| Diabetes Mellitus | 3 |
| Metabolic Syndrome | 3 |
Showing 5 of 29 disease areas.
Trials by start year as sponsor or collaborator (7)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year. 1 trial is registered to start in 2027 or later, and not listed here.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 4 |
| 2023 | 3 |
| 2022 | 3 |
| 2021 | 4 |
| 2020 | 2 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 2 hit target (n=2) | 1 of 1 on time (n=1) |
Journals published in (70)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Nutrients | 5 |
| Journal of neuroengineering and rehabilitation | 4 |
| Spinal cord | 4 |
| Cancer prevention research (Philadelphia, Pa.) | 3 |
| Expert review of anti-infective therapy | 3 |
Showing 5 of 70 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 455 | 88 | 2025-12-09 |
Organization relationships (7)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Junta de Andalucía | Parent of | 1 |
| Servicio de Salud de Castilla La Mancha | Co sponsors trial with | 1 |
| Fundación Ciencia y Estudios Aplicados para el Desarrollo en Salud y Medio Ambiente (CEADES) | Co sponsors trial with | 1 |
| University of Texas, El Paso | Co sponsors trial with | 1 |
| BioRobotics Group - Spanish National Research Council (CSIC) | Co sponsors trial with | 1 |
Showing 5 of 7 relationships.
Latest dated events (491)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-21 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-01-12 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-12-09 | Patent granted | Granted US patents (PatentsView / USPTO) |
| 2025-11-18 | Patent granted | Granted US patents (PatentsView / USPTO) |
Showing 5 of 491 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| FAP | Trial collaborator | Named in trial exclusion criteria |
| FAP | Trial collaborator | Mentioned in trial text |
Biomarkers this organization publishes on (230)
Shown in this order: most publications first.
Showing 5 of 230 biomarkers.
On Scientist.com
Spanish National Research Council is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, active development programs, approved assets, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with IPBLN CSIC Instituto de Parasitologia y Biomedicina "Lopez Neyra" (CSIC) on Scientist.com
For prices, more details, or to contact IPBLN CSIC Instituto de Parasitologia y Biomedicina "Lopez Neyra" (CSIC), visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.